Skip to main content
. 2021 Oct 4;20:199. doi: 10.1186/s12933-021-01392-6

Fig. 2.

Fig. 2

Empagliflozin did not alter baseline ECGs. A Exemplar baseline surface ECGs from rats with or without empagliflozin. CON, control; Em, empagliflozin. B Quantification of ECG parameters; n = 13–15. All group comparisons, P > 0.05. CON, control; Em, empagliflozin. RR, RR interval; HR, heart rate; PR, PR interval; QRS, QRS interval; QT, QT interval; QTc: QT interval calculated based on Mitchell’s formula (see “Materials and methods”)